Literature DB >> 23344308

Recognition and management of psychosis and schizophrenia in children and young people: summary of NICE guidance.

Tim Kendall1, Chris Hollis, Megan Stafford, Clare Taylor.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23344308     DOI： 10.1136/bmj.f150

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  15 in total

Review 1.  [Revised S3 guidelines on schizophrenia : Developmental process and selected recommendations].

Authors:  Alkomiet Hasan; Peter Falkai; Isabel Lehmann; Birgit Janssen; Thomas Wobrock; Jürgen Zielasek; Wolfgang Gaebel
Journal:  Nervenarzt       Date:  2020-01       Impact factor: 1.214

2.  Outcome of Youth with Early-Phase Schizophrenia-Spectrum Disorders and Psychosis Not Otherwise Specified Treated with Second-Generation Antipsychotics: 12 Week Results from a Prospective, Naturalistic Cohort Study.

Authors:  Ditte L Vernal; Sandeep Kapoor; Aseel Al-Jadiri; Eva M Sheridan; Yehonathan Borenstein; Charles Mormando; Lisa David; Sukhbir Singh; Andrew J Seidman; Maren Carbon; Miriam Gerstenberg; Ema Saito; John M Kane; Hans-Christoph Steinhausen; Christoph U Correll
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-09       Impact factor: 2.576

Review 3.  A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia.

Authors:  Rebecca C Harvey; Anthony C James; Gemma E Shields
Journal:  CNS Drugs       Date:  2016-01       Impact factor: 5.749

4.  Psychosocial Interventions in Reducing Cannabis Use in Early Phase Psychosis: A Canadian Survey of Treatments Offered.

Authors:  Cristina Aydin; Philip G Tibbo; Zenovia Ursuliak
Journal:  Can J Psychiatry       Date:  2016-03-16       Impact factor: 4.356

5.  Epidemiology of Psychotic Disorders Based on Demographic Variables in Iranian Children and Adolescents.

Authors:  Seyyed Salman Alavi; Mohammad Reza Mohammadi; Zahra Hooshyari; Soroush Mohammadi Kalhori; Mona Salehi; Maryam Salmanian; Ali Khaleghi; Hadi Zarafshan; Ameneh Ahmadi; Koorosh Kamali; Nastran Ahmadi
Journal:  Iran J Psychiatry       Date:  2021-01

6.  Recognition and management of depression in early psychosis.

Authors:  Zainab Bashir; Sian Lowri Griffiths; Rachel Upthegrove
Journal:  BJPsych Bull       Date:  2022-04

Review 7.  Efficacy and safety of pharmacological and psychological interventions for the treatment of psychosis and schizophrenia in children, adolescents and young adults: a systematic review and meta-analysis.

Authors:  Megan R Stafford; Evan Mayo-Wilson; Christina E Loucas; Anthony James; Chris Hollis; Max Birchwood; Tim Kendall
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

8.  Coping with Unusual ExperienceS for 12-18 year olds (CUES+): a transdiagnostic randomised controlled trial of the effectiveness of cognitive therapy in reducing distress associated with unusual experiences in adolescent mental health services: study protocol for a randomised controlled trial.

Authors:  Suzanne Jolley; Sophie Browning; Richard Corrigall; Kristin R Laurens; Colette Hirsch; Karen Bracegirdle; Kimberley Gin; Francesca Muccio; Catherine Stewart; Partha Banerjea; Elizabeth Kuipers; Philippa Garety; Majella Byrne; Juliana Onwumere; Evanthia Achilla; Paul McCrone; Richard Emsley
Journal:  Trials       Date:  2017-12-04       Impact factor: 2.279

9.  Early- Versus Adult-Onset Schizophrenia as a Predictor of Response to Neuroscience-Informed Cognitive Training.

Authors:  Olga Puig; Melissa Fisher; Rachel Loewy; Kathleen Miley; Ian S Ramsay; Cameron S Carter; John D Ragland; Tara Niendam; Sophia Vinogradov
Journal:  J Clin Psychiatry       Date:  2020-03-03       Impact factor: 4.384

Review 10.  Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials.

Authors:  A K Pagsberg; S Tarp; D Glintborg; A D Stenstrøm; A Fink-Jensen; C U Correll; R Christensen
Journal:  BMJ Open       Date:  2014-10-10       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.